NCT05609032Completed
Development and Pilot Testing of the Sense2Quit App
Source: ClinicalTrials.gov · Last updated 6 Nov 2024
Brief summary (registry, in English)
This is a pilot randomized controlled trial to examine the feasibility, acceptability and preliminary efficacy of the Sense2Quit App in a sample of 60 PLWH who smoke.
- Status (registry)
- Completed
- Study type
- Interventional
- Enrollment
- 60 (actual)
- First submitted
- 14 Jul 2022
- Start date
- 6 Mar 2023
- Primary completion date
- 12 Jan 2024
- Lead sponsor
- Columbia University
- Diseases
- HIV
- NCT number
- NCT05609032
What you commit to
- Study type: Interventional
- Participants enrolled: 60
- From 6 Mar 2023 to the primary completion date, 12 Jan 2024
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Current use of NRT or other smoking cessation medications (e.g., Chantix or Zyban);
Other illness
- Positive history of a medical condition that precludes nicotine patch use;
Other
- Use of tobacco products other than cigarettes (i.e. cigars, piped tobacco, chew, snuff)
- Planning to move within 3 months of enrollment;
- Current enrollment in another smoking cessation program.
- Alcohol dependence measured through the AUDIT-C
- A household member is also participating in the Sense2Quit study (due to study contamination).
Who the study is looking for
- PLWH confirmed through medical records or pill bottles for antiretroviral therapy (ART)medications.
- ≥ 18 years of age;
- Own an Android smartphone;
- Understand and read English;
- Not pregnant or breastfeeding (due to contraindications for Nicotine Replacement Therapy \[NRT\]);
- Permanent contact information;
- Smokes ≥5 cigarettes per day for the past 30 days;
- Interested in quitting smoking within 30 days;
- Blows ≥5 ppm eCO into a breath analyzer at baseline.
Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Columbia University Irving Medical Center Coordinator of this site? Confirm its status | New York | United States | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.